Scientists study immune response to COVID-19 in patients with different levels of disease severity

Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.

Related Keywords

Russia ,Skolkovo ,Samarskaya Oblast ,Russian ,Maria Tutukina ,Anna Kaznadzey ,Emily Henderson ,Russian Academy Of Sciences ,Institute Of Cell Biophysics ,Skolkovo Institute Of Science ,Institute For Information Transmission Problems ,Argentys Informatics ,Russian Academy ,Study First Author ,Cell Biophysics ,Information Transmission Problems ,Skolkovo Institute ,Antibodies ,Ntibody ,Flood ,Fell ,Coronavirus ,It ,Immune Response ,Immunity ,Protein ,Eceptor ,Research ,Spike Protein ,Virus ,